Apoptosis, Induced by Human ?-Synuclein in Yeast, Can Occur Independent of Functional Mitochondria.
Ontology highlight
ABSTRACT: Human ?-synuclein expression in baker's yeast reportedly induces mitochondria-dependent apoptosis. Surprisingly, we find that, under de-repressing conditions of the inducible MET25/GAL1 promoters, yeast cells expressing chromosomally-integrated copies of the human ?-synuclein gene are not killed, but spontaneously form respiration-deficient rho-minus (?-) petites. Although yeast cells can undergo cell death (apoptosis) from loss of mitochondrial function, they can also survive without functional mitochondria. Such cells are referred to as ?0 or ?- petites. This study reports that minimal expression of human ?-synuclein in yeast, from MET25/GAL1 promoter, gives rise to ?- petites. Interestingly, the full expression of ?-synuclein, from the same promoters, in ?-synuclein-triggered ?- petites and also in ?0 petites (produced by treating ?+ cells with the mutagen ethidium bromide) initiates apoptosis. The percentages of petites increase with increasing ?-synuclein gene copy-number. ?- petites expressing ?-synuclein from fully-induced MET25/GAL1 promoters exhibit increased ROS levels, loss of mitochondrial membrane potential, and nuclear DNA fragmentation, with increasing copies of ?-synuclein. Our results indicate that, for the first time in yeast, ?-synuclein-triggered apoptosis can occur independently of functional mitochondria. The observation that ?-synuclein naturally forms petites and that they can undergo apoptosis may have important implications in understanding the pathogenesis of Parkinson's disease.
SUBMITTER: Akintade DD
PROVIDER: S-EPMC7601298 | biostudies-literature | 2020 Sep
REPOSITORIES: biostudies-literature
ACCESS DATA